Photo: minkherapeutics.com
Mar 24, 2024, 13:10
MiNK Therapeutics announced results for the fourth quarter and year-end of 2023
MiNK Therapeutics shared on their LinkedIn page:
“Today MiNK announced results for the fourth quarter and year-end of 2023. Our year was marked by progress across our clinical programs, manufacturing capabilities, and research team, which continue to solidify MiNK’s leadership in the field of iNKT cell therapy.
Read more about the results and our plans for 2024 here.”
Source: MiNK Therapeutics/LinkedIn